ES521389A0 - Un metodo para preparar derivados de tiazolidina. - Google Patents
Un metodo para preparar derivados de tiazolidina.Info
- Publication number
- ES521389A0 ES521389A0 ES521389A ES521389A ES521389A0 ES 521389 A0 ES521389 A0 ES 521389A0 ES 521389 A ES521389 A ES 521389A ES 521389 A ES521389 A ES 521389A ES 521389 A0 ES521389 A0 ES 521389A0
- Authority
- ES
- Spain
- Prior art keywords
- thiazolidine derivatives
- preparing
- preparing thiazolidine
- derivatives
- thiazolidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57062223A JPS58177983A (ja) | 1982-04-13 | 1982-04-13 | チアゾリジン誘導体 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES521389A0 true ES521389A0 (es) | 1984-11-01 |
ES8500919A1 ES8500919A1 (es) | 1984-11-01 |
Family
ID=13193933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES521389A Expired ES8500919A1 (es) | 1982-04-13 | 1983-04-12 | Un metodo para preparar derivados de tiazolidina. |
Country Status (8)
Country | Link |
---|---|
US (1) | US4486594A (es) |
EP (1) | EP0091761B1 (es) |
JP (1) | JPS58177983A (es) |
CA (1) | CA1194881A (es) |
DE (1) | DE3374561D1 (es) |
ES (1) | ES8500919A1 (es) |
GR (1) | GR78829B (es) |
PT (1) | PT76540B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK4487A (da) * | 1986-01-07 | 1987-07-08 | Yamanouchi Pharma Co Ltd | Heterocycliske forbindelser og farmaceutiske praeparater indeholdende disse |
US5053420A (en) * | 1989-10-13 | 1991-10-01 | Pershadsingh Harrihar A | Thiazolidine derivatives for the treatment of hypertension |
US5594015A (en) * | 1994-06-22 | 1997-01-14 | Regents Of The University Of California | Thiazolidine derivatives for the treatment of psoriasis |
US6756360B1 (en) | 1998-12-24 | 2004-06-29 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes |
JP2001072592A (ja) | 1999-07-01 | 2001-03-21 | Kyowa Hakko Kogyo Co Ltd | テロメラーゼ阻害剤 |
US7563774B2 (en) | 2000-06-29 | 2009-07-21 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
US6452014B1 (en) | 2000-12-22 | 2002-09-17 | Geron Corporation | Telomerase inhibitors and methods of their use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1222411A (fr) * | 1955-05-19 | 1960-06-09 | Searle & Co | Procédé de préparation de 2,4-diaminothiazols contenant un radical aryle halogéné |
US3864384A (en) * | 1970-05-05 | 1975-02-04 | Rorer Inc William H | Substituted phenylacetic acid compounds |
JPS5697277A (en) * | 1980-01-07 | 1981-08-05 | Takeda Chem Ind Ltd | Thiazolidine derivative |
AU6610081A (en) * | 1980-01-24 | 1981-07-30 | Senju Pharmaceutical Co., Ltd. | Thiazolidine derivatives |
-
1982
- 1982-04-13 JP JP57062223A patent/JPS58177983A/ja active Granted
-
1983
- 1983-03-31 EP EP83301847A patent/EP0091761B1/en not_active Expired
- 1983-03-31 DE DE8383301847T patent/DE3374561D1/de not_active Expired
- 1983-04-11 GR GR71045A patent/GR78829B/el unknown
- 1983-04-12 CA CA000425697A patent/CA1194881A/en not_active Expired
- 1983-04-12 ES ES521389A patent/ES8500919A1/es not_active Expired
- 1983-04-12 PT PT76540A patent/PT76540B/pt not_active IP Right Cessation
- 1983-04-13 US US06/484,549 patent/US4486594A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US4486594A (en) | 1984-12-04 |
JPS58177983A (ja) | 1983-10-18 |
EP0091761B1 (en) | 1987-11-19 |
DE3374561D1 (en) | 1987-12-23 |
EP0091761A3 (en) | 1984-12-27 |
PT76540A (en) | 1983-05-01 |
GR78829B (es) | 1984-10-02 |
CA1194881A (en) | 1985-10-08 |
JPH0119390B2 (es) | 1989-04-11 |
ES8500919A1 (es) | 1984-11-01 |
EP0091761A2 (en) | 1983-10-19 |
PT76540B (en) | 1985-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES505373A0 (es) | Un metodo para preparar derivados de fenilpiperazina | |
ES530024A0 (es) | Un procedimiento para preparar derivados de pirazinona | |
ES528304A0 (es) | Un procedimiento para preparar derivados de pirimidona | |
ES530391A0 (es) | Un metodo para preparar derivados de 4-hidroxi-2-quinolona. | |
ES528003A0 (es) | Un procedimiento para preparar derivados de cefem | |
ES527994A0 (es) | Un procedimiento para preparar derivados de piridina. | |
ES530019A0 (es) | Un metodo para preparar derivados de 3-metilflavona | |
ES507065A0 (es) | Un metodo para preparar derivados de 2-oxoazetidina. | |
ES527304A0 (es) | Un procedimiento para preparar derivados de pirimidona. | |
ES521955A0 (es) | Un procedimiento para preparar derivados de cefalosporina. | |
ES521361A0 (es) | Un metodo para preparar un derivado 14-acilico de lankacidina. | |
ES521389A0 (es) | Un metodo para preparar derivados de tiazolidina. | |
ES520709A0 (es) | Un procedimiento para preparar derivados de piridina. | |
ES507975A0 (es) | Un metodo para preparar derivados de pirazolina. | |
ES527705A0 (es) | Un metodo para preparar derivados de fenotiazina | |
ES519936A0 (es) | Un procedimiento para preparar derivados de pirimidona. | |
ES538036A0 (es) | Un procedimiento para preparar derivados de piridona. | |
ES522716A0 (es) | Un procedimiento para preparar un derivado de pirazol. | |
ES520439A0 (es) | Un metodo para preparar derivados de fenilpiperazina. | |
ES526177A0 (es) | Un procedimiento para preparar derivados de pirimidona | |
ES537999A0 (es) | Un procedimiento para preparar un derivado de rodanina | |
ES538032A0 (es) | Un procedimiento para preparar derivados de isoxazolamina. | |
ES506930A0 (es) | Un procedimiento para preparar derivados de n-fenil-dicloro-maleimida. | |
ES508928A0 (es) | Un procedimiento para preparar derivados de n-acil-n-hidroxi-a minoacidos. | |
ES506302A0 (es) | Un procedimiento para preparar derivados de tetrahidroiso- quinoleinas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19970303 |